Javascript must be enabled to continue!
Identification of Candida auris in a foreign repatriated patient to Ontario, Canada and infection control strategies to prevent transmission
View through CrossRef
Background: Candida auris (C. auris) is an emerging fungus which presents a global health threat with increased morbidity and mortality in hospitalized patients. Upon identification of our first case of C. auris on admission from a foreign hospital, we set out to implement infection prevention and control (IPAC) measures to prevent transmission.
Methods: We conducted a prospective surveillance of C. auris in a community teaching hospital from April 2019 to November 2020. We also implemented protocols to prevent C. auris infection such as staff education and training; establishing policy/procedures for screening and testing of patients at risk and/or colonized with C. auris; validation of microbiology methodology, cleaning and disinfection protocols to prevent equipment and environmental contamination, and patient and family information.
Results: Following this prospective surveillance program, a positive case of C. auris was identified from a high-risk patient admitted to the hospital. After identification of the case of C. auris, over 600 unit mates (patients on the same unit) were screened, and multiple environmental specimens were tested for C. auris, but no additional case was detected or evidence of hospital-acquired transmission over the 19-month hospitalization of the case.
Conclusion: Multidisciplinary approach, extra resources and senior management support are necessary to prevent and control transmission of C. auris within the healthcare setting.
Infection Prevention and Control Canada
Title: Identification of Candida auris in a foreign repatriated patient to Ontario, Canada and infection control strategies to prevent transmission
Description:
Background: Candida auris (C.
auris) is an emerging fungus which presents a global health threat with increased morbidity and mortality in hospitalized patients.
Upon identification of our first case of C.
auris on admission from a foreign hospital, we set out to implement infection prevention and control (IPAC) measures to prevent transmission.
Methods: We conducted a prospective surveillance of C.
auris in a community teaching hospital from April 2019 to November 2020.
We also implemented protocols to prevent C.
auris infection such as staff education and training; establishing policy/procedures for screening and testing of patients at risk and/or colonized with C.
auris; validation of microbiology methodology, cleaning and disinfection protocols to prevent equipment and environmental contamination, and patient and family information.
Results: Following this prospective surveillance program, a positive case of C.
auris was identified from a high-risk patient admitted to the hospital.
After identification of the case of C.
auris, over 600 unit mates (patients on the same unit) were screened, and multiple environmental specimens were tested for C.
auris, but no additional case was detected or evidence of hospital-acquired transmission over the 19-month hospitalization of the case.
Conclusion: Multidisciplinary approach, extra resources and senior management support are necessary to prevent and control transmission of C.
auris within the healthcare setting.
Related Results
Growth phase influences virulence in
Candidozyma auris
systemic infection models
Growth phase influences virulence in
Candidozyma auris
systemic infection models
Abstract
Candidozyma auris
is a growing public health concern, capable of causing long-term contamination of healthcare setting...
Case of Candida auris Identified From the External Ear Canal of a Healthy Minnesota Outpatient With Travel to South Korea
Case of Candida auris Identified From the External Ear Canal of a Healthy Minnesota Outpatient With Travel to South Korea
Background:Candida auris is a globally emerging, multidrug-resistant fungal pathogen that causes healthcare-associated outbreaks and can be misidentified in clinical laboratories. ...
Características Epidemiológicas da Levedura Emergente Candida auris
Características Epidemiológicas da Levedura Emergente Candida auris
As infecções fúngicas são cada vez mais reconhecidas como uma ameaça mundial à saúde humana. A espécie de Candida, denominada como Candida auris tem adquirido um grande destaque de...
Candida auris case in Karachi, a public health threat ahead
Candida auris case in Karachi, a public health threat ahead
Candida auris a multidrug- resistant nosocomial fungal pathogen is an emerging global public health threat. Since its discovery in Japan in 2009, the fungus has now affected more t...
P-1057. Candidozyma (Candida) auris in the United States: Insights from the SHEA Research Network
P-1057. Candidozyma (Candida) auris in the United States: Insights from the SHEA Research Network
Abstract
Background
We queried the Society for Healthcare Epidemiology (SHEA) Research Network (SRN) regarding C. auris p...
Synergistic Interactions between Pseudomonas aeruginosa and Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis as well as Candida tropicalis in the Formation of Polymicrobial Biofilms
Synergistic Interactions between Pseudomonas aeruginosa and Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis as well as Candida tropicalis in the Formation of Polymicrobial Biofilms
The interactions between pathogens during infection and the impact of these interactions on drug effectiveness are poorly understood, making polymicrobial infections challenging to...
Hefebefunde bei Reihenuntersuchungen an Soldaten der Bundeswehr
Hefebefunde bei Reihenuntersuchungen an Soldaten der Bundeswehr
ZusammenfassungBei Reihenuntersuchungen an 1325 Soldaten wurde die Sproßpilzbesiedlung der Mund‐böhle (1325 Abstriche), der Analregion (949 Abstriche), des Penis (1325 Abklatsch‐Ku...
Toward point-of-care diagnostics of
Candida auris
Toward point-of-care diagnostics of
Candida auris
Abstract
Candida auris
is a multidrug-resistant yeast that presents global health threat for the hospitalized patients. Early d...

